Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Herpesviridae infectious disease, Infections, Primary Immunodeficiency Diseases, cytomegalovirus infection, hereditary disease, immune system disorder, inborn error of immunity, viral infectious disease	Recruiting	Phase 2	2025-08-08		NCT03266640

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital Los Angeles	90
Children's Hospital of Philadelphia	215
Indiana University	297
Johns Hopkins University	579
Medical College of Wisconsin	201
Nationwide Children's Hospital	97
New York Medical College	28
University of California, San Francisco	637
Washington University School of Medicine	475

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital Los Angeles	Los Angeles	United States	226
Children's Hospital of Pennsylvania	Philadelphia	United States	8
Indiana University	Indianapolis	United States	160
Johns Hopkins	Baltimore	United States	39
Medical College of Wisconsin/Children's Hospital of Wisconsin	Milwaukee	United States	6
Nationwide Children's Hosptial	Columbus	United States	9
New York Medical College	Valhalla	United States	71
University of California San Francisco	San Francisco	United States	80
Washington University	St Louis	United States	34